| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -4.3e-05 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |